Circulating CD34+ Cells: A New Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism

Nicolas Gendron; Nicolas Gendron; Benjamin Planquette; Benjamin Planquette; Anne Roche; Anne Roche; Richard Chocron; Richard Chocron; Dominique Helley; Dominique Helley; Aurélien Philippe; Aurélien Philippe; Pierre‐Emmanuel Morange; Pierre‐Emmanuel Morange; Pascale Gaussem; Pascale Gaussem; Olivier Sanchez; Olivier Sanchez; David M. Smadja; David M. Smadja

doi:10.1007/s12015-025-10865-0

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta‐analysis

Cecilia Becattini, Michela Giustozzi, Pau Cerdà, Ludovica Anna Cimini, Antoni Riera‐Mestre, Giancarlo Agnelli

Article2016

Circulating endothelial cells: a new biomarker of endothelial dysfunction in hematological diseases

Nicolas Gendron, Nicolas Gendron, David M. Smadja, David M. Smadja

Letter2024

Circulating endothelial cells: a key biomarker of persistent fatigue after hospitalization for COVID-19

David M. Smadja, David M. Smadja, Sven Günther, Sven Günther, Pauline Cavagna, Pauline Cavagna, Bertrand Renaud, Bertrand Renaud, Dominique Salmon, Dominique Salmon, Bertrand Hermann, Bertrand Hermann, Brigitte Ranque, Brigitte Ranque, Cédric Lemogne, Cédric Lemogne, Jean-Luc Diehl, Jean-Luc Diehl, Aurélien Philippe, Aurélien Philippe

Article2006

Incidence of Chronic Thromboembolic Pulmonary Hypertension After a First Episode of Pulmonary Embolism

Cecilia Becattini, Giancarlo Agnelli, Raffaele Pesavento, Mauro Silingardi, Renzo Poggio, Maria Rita Taliani, Walter Ageno

Article2015

Circulating endothelial cells: new biomarker of the endothelial dysfunction in hematological malignancies

Nicolas Gendron, Nicolas Gendron, David M. Smadja, David M. Smadja